The Board of Directors gave a mandate for negotiations for the sale of the shares owned by the Company in its subsidiaries "Veta Pharma" AD and "Aromania" AD

Sofia, Bulgaria, December 23, 2020 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Board of Directors gave a mandate to the Executive director and the Procurator of the company to negotiate for the sale of the shares owned by “Sopharma” AD in its subsidiaries “Veta Pharma” AD and “Aromania” AD.